Login to Your Account

Other News To Note

Wednesday, November 6, 2013
• SRI International, of Menlo Park, Calif., said it was awarded a five-year contract valued up to $9.75 million from the National Institute on Drug Abuse to conduct preclinical safety studies of potential new medicines to treat substance abuse.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription